|
Market Cap (5-Jun) $3,468,719 (1,786th) |
Close (30-Jun) $0.055 |
Volume (30-Jun) 26,598 |
Shortsold (27-Apr) 9,446 (0.01%) (422nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
AMT released this announcement to the ASX on 21 December 2020, 9:44. The announcement is marked as price sensitive, and is 2 page(s) in length and 189.67kb in size.
You can view all announcements from AMT and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AMT | |
|---|---|
| Extension of Loan Agreement with RIPL | 28 June 2023, 8:30 |
| Company Update on Sale of Orthopaedic Asset | 2 May 2023, 19:15 |
| AMT Submits 510(k) for Spinal Cage FDA Clearance | 31 March 2023, 8:21 |
| Further Positive Test Results - Spinal Cage Device | 21 December 2020, 9:44 |
| Spinal Cage Device Positive Test Results | 4 December 2020, 11:44 |
| Change of Director's Interest Notice | 10 November 2020, 19:30 |
| Appendix 3G | 10 November 2020, 19:10 |
You must be logged in to post a reply.
